Spinal disc implant to be sold in Europe:
This article was originally published in Clinica
RayMedica, a small US developer of devices to treat back pain, has CE-marked its PDN prosthetic disc nucleus devices and instrumentation. The Minneapolis, Minnesota-based company plans to launch the PDN implant in all EU countries after it has trained groups of surgeons in each country. Two of the devices, which are hydrogel cores covered with woven polyethylene, are implanted within the spinal disc of patients with low back pain, where they expand by absorbing fluid, taking pressure off the disc.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.